Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for down’s syndrome.
Open accessAbstract
Down's syndrome (DS), with an incidence of one in 800 live births, is the most common genetic disorder associated with mental retardation. This trisomy on chromosome 21 induces a variable phenotype in which the only common feature is the presence of mental retardation. The neural mechanisms underlying mental retardation might include defects in the formation of neuronal networks and neural plasticity. DS patients have alterations in the morphology, the density and the distribution of dendritic spines in the pyramidal neurons of the cortex. Our hypothesis is that the deficits in dendritic arborization observed in the principal neurons of DS patients and Ts65Dn mice (a model for DS that mimics most of the structural alterations observed in humans) may be mediated to some extent by changes in their inhibitory inputs. Different types of interneurons control different types of inhibition. Therefore, to understand well the changes in inhibition in DS, it is necessary to study the different types of interneurons separately. We have studied the expression of synaptophysin, Glutamic acid decarboxylase-67 (GAD-67) and calcium-binding protein-expressing cells in the primary somatosensory cortex of 4-5 month old Ts65Dn mice. We have observed an increment of GAD67 immunoreactivity that is related mainly to an increment of calretinin-immunoreactive cells and among them the ones with bipolar morphology. Since there is a propensity for epilepsy in DS patients, this increase in interneurons might reflect an attempt by the system to block overexcitation rather than an increment in total inhibition and could explain the deficit in interneurons and principal cells observed in elderly DS patients.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Ts65Dn neocortex, there is an increase in the density of calretinin positive interneurons, no overall increase in parvalbumin interneurons, and altered distribution of both interneuron types throughout cortical layers.
“another study found that there was an increase in the density of calretinin positive interneurons in the Ts65Dn neocortex and no overall increase in parvalbumin interneurons though the distribution of both interneurons types was significantly altered throughout the layers of the cortex (Pérez-Cremades et al., 2010).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Pérez-Cremades et al., 2010
The paper’s opening passage (p. 445) reports an increase in calretinin-immunoreactive cells in the somatosensory cortex of Ts65Dn mice. The available Results passage (p. 447) reports layer-specific changes for interneurons overall, but does not establish that parvalbumin interneurons showed no overall increase or that both named subtypes had significantly altered distributions across layers. (LLM, conf=0.76)
Experimental — accuracy not yet measuredStriking conservation was found in the ratio of ExN:InN (2.17:1) and the ratio of MGE:CGE InNs (1.4:1) in both control and Ts21 samples.
“Whereas Ts21 mouse models have identified alterations in the balance of ExN and InN (43-45), we found striking conservation in the ratio of ExN:InN (2.17:1) and the ratio of MGE:CGE InNs (1.4:1) in both control and Ts21 samples (Fig. 4B).”
From Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex (2026) · cites this paper as [43]
The Results (p. 447) report increased interneuron density in the somatosensory cortex of Ts65Dn mice, and the introduction (p. 446) discusses an imbalance of excitatory and inhibitory inputs. The paper does not measure an excitatory-to-inhibitory neuron ratio, so it supports the cited background point about altered inhibition but not the more specific claim about ExN:InN balance. The numerical ratios and their conservation are the citing authors’ own finding, not attributed to this source. (LLM, conf=0.84)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Interneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · see citing works
Roizen, N., & Patterson, D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12987-x · Cited by 1,333 · see citing works
A mouse model for Down syndrome exhibits learning and behaviour deficits
Reeves, R. H., Irving, N. G., Moran, T. H., Wohn, A., Kitt, C., Sisodia, S. S., Schmidt, C., Bronson, R. T., & Davisson, M. T. (1995) · Nature Genetics · doi:10.1038/ng1095-177 · Cited by 913 · see citing works
Molecular and Physiological Diversity of Cortical Nonpyramidal Cells
Cauli, B., Audinat, E., Lambolez, B., Angulo, M. C., Ropert, N., Tsuzuki, K., Hestrin, S., & Rossier, J. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03894.1997 · Cited by 738 · see citing works
Dendritic Anomalies in Disorders Associated with Mental Retardation
Kaufmann, W. E. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.10.981 · Cited by 733 · see citing works
Wichterle, H., Turnbull, D. H., Nery, S., Fishell, G., & Alvarez-Buylla, A. (2001) · Development · doi:10.1242/dev.128.19.3759 · Cited by 722 · see citing works
Origin of GABAergic neurons in the human neocortex
Letinić, K., Zoncu, R., & RAKIC, P. T. (2002) · Nature · doi:10.1038/nature00779 · Cited by 718 · see citing works
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome
Fernandez, F., Morishita, W., Zuniga, E., Nguyen, J., Blank, M., Malenka, R. C., & Garner, C. C. (2007) · Nature Neuroscience · doi:10.1038/nn1860 · Cited by 509 · see citing works
Condé, F., Lund, J. S., Jacobowitz, D. M., Baimbridge, K. G., & Lewis, D. A. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903410109 · Cited by 500 · see citing works
Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome
Holtzman, D. M., Santucci, D., Kilbridge, J., Chua-Couzens, J., Fontana, D. J., Daniels, S. E., Johnson, R. M., Chen, K., Sun, Y., Carlson, E., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13333 · Cited by 448 · see citing works
Takashima, S., Becker, L. E., Armstrong, D. L., & Chan, F. (1981) · Brain Research · doi:10.1016/0006-8993(81)90314-0 · Cited by 307 · see citing works
Synaptic structural abnormalities in the Ts65Dn mouse model of down syndrome
Belichenko, P. V., Masliah, E., Kleschevnikov, A. M., Villar, A. J., Epstein, C. J., Salehi, A., & Mobley, W. C. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20337 · Cited by 297 · see citing works
Pyramidal cell abnormalities in the motor cortex of a child with Down's syndrome. A Golgi study
Marin‐Padilla, M. (1976) · Journal of Comparative Neurology · doi:10.1002/cne.901670105 · Cited by 285 · see citing works
Dendritic atrophy in children with down’s syndrome.
Becker, L. E., Armstrong, D. L., & Chan, F. (1986) · Annals of Neurology · doi:10.1002/ana.410200413 · Cited by 279 · see citing works
Masliah, E., Terry, R. D., Alford, M. F., & DeTeresa, R. M. (1990) · Journal of Histochemistry & Cytochemistry · doi:10.1177/38.6.2110586 · Cited by 267 · see citing works
Eastwood, S. L., & Harrison, P. J. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00530-5 · Cited by 262 · see citing works
Calretinin and calbindin-D28k in rat brain: Patterns of partial co-localization
ROGERS, J. H., & Résibois, A. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90525-7 · Cited by 242 · see citing works
A behavioral assessment of Ts65Dn mice: a putative Down syndrome model
Escorihuela, R. M., Fernández‐Teruel, A., Vallina, I. F., Baamonde, C., Lumbreras, M., Dierssen, M., Tobeña, A., & Flórez, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12052-6 · Cited by 234 · see citing works
Gardiner, K., Fortna, A., Bechtel, L. J., & Davisson, M. T. (2003) · Gene · doi:10.1016/s0378-1119(03)00769-8 · Cited by 203 · see citing works
Belichenko, P. V., Kleschevnikov, A. M., Salehi, A., Epstein, C. J., & Mobley, W. C. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21433 · Cited by 202 · see citing works
Down's syndrome: Is there a decreased population of neurons?
Ross, M. H., Galaburda, A. M., & Kemper, T. L. (1984) · Neurology · doi:10.1212/wnl.34.7.909 · Cited by 191 · see citing works
Dendritic pathology in mental retardation: from molecular genetics to neurobiology
Dierssen, M., & Ramakers, G. J. A. (2006) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2006.00224.x · Cited by 190 · see citing works
Meskenaïte, V. (1997) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19970303)379:1 · Cited by 180 · see citing works
Distinct Origins of Neocortical Projection Neurons and Interneurons In Vivo
Anderson, S. A. (2002) · Cerebral Cortex · doi:10.1093/cercor/12.7.702 · Cited by 179 · see citing works
ROGERS, J. H. (1992) · Brain Research · doi:10.1016/0006-8993(92)91439-l · Cited by 174 · see citing works
Gabbott, P. L. A., & Bacon, S. J. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960122)364:4 · Cited by 165 · see citing works
Motor dysfunction in a mouse model for Down syndrome
Costa, A. C. S., WALSH, K., & Davisson, M. T. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00178-x · Cited by 161 · see citing works
Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome
Escorihuela, R. M., Vallina, I. F., Martínez‐Cué, C., Baamonde, C., Dierssen, M., Tobeña, A., Flórez, J., & Fernández‐Teruel, A. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00317-6 · Cited by 161 · see citing works
Caputi, A., Rozov, A., Blatow, M., & Monyer, H. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn175 · Cited by 154 · see citing works
Dierssen, M. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.7.758 · Cited by 148 · see citing works
Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of down syndrome.
Belichenko, P. V., Kleschevnikov, A. M., Masliah, E., Wu, C., Takimoto‐Kimura, R., Salehi, A., & Mobley, W. C. (2009) · Journal of Comparative Neurology · doi:10.1002/cne.21895 · Cited by 141 · see citing works
Dendrites, dementia and the down syndrome
Takashima, S., Ieshima, A., Nakamura, H., & Becker, L. E. (1989) · Brain and Development · doi:10.1016/s0387-7604(89)80082-8 · Cited by 128 · see citing works
Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice
Kurt, M. A., Davies, D. C., Kidd, M., Dierssen, M., & Flórez, J. (2000) · Brain Research · doi:10.1016/s0006-8993(00)01984-3 · Cited by 127 · see citing works
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
Hunter, C. L., Bachman, D., & Granholm, A. (2004) · Annals of Neurology · doi:10.1002/ana.20250 · Cited by 120 · see citing works
Connectivity of GABAergic Calretinin-immunoreactive Neurons in Rat Primary Visual Cortex
Gonchar, Y. (1999) · Cerebral Cortex · doi:10.1093/cercor/9.7.683 · Cited by 117 · see citing works
Chronic fluoxetine treatment increases the expression of PSA-NCAM in the medial prefrontal cortex
Varea, E., Blasco-Ibáñez, J. M., Gómez-Climent, M. Á., Castillo-Gómez, E., Crespo, C., Martínez-Guijarro, F. J., & Nácher, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301183 · Cited by 96 · see citing works
Self-citationCortical Interneuron Fate Determination: Diverse Sources for Distinct Subtypes?
Xu, Q. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.6.670 · Cited by 82 · see citing works
Distribution of parvalbumin immunoreactivity in the neocortex of hypothyroid adult rats
Berbel, P. J., Marco, P., Cerezo, J. R., & DeFelipe, J. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12318-1 · Cited by 81 · see citing works
Epilepsy in Down syndrome: clinical aspects and possible mechanisms.
Stafstrom, C. E. (1993) · PubMed · Cited by 77 · see citing works
Schierle, G. S. K. (1997) · Cerebral Cortex · doi:10.1093/cercor/7.2.130 · Cited by 69 · see citing works
Altered organization of cortical interneurons in rats exposed to ethanol during neonatal life
Granato, A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.11.024 · Cited by 62 · see citing works
Cerebral cortical calbindin D28K and parvalbumin neurones in Down's syndrome
Kobayashi, K., Emson, P. C., Mountjoy, C. Q., Thornton, S. N., Lawson, D. E. M., & Mann, D. M. A. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90487-t · Cited by 57 · see citing works
Perinatal growth of prefrontal layer III pyramids in down syndrome
Vukšić, M., Petanjek, Z., Rašin, M. R., & Kostović, I. (2002) · Pediatric Neurology · doi:10.1016/s0887-8994(02)00380-6 · Cited by 56 · see citing works
Ethanol Induces Heterotopias in Organotypic Cultures of Rat Cerebral Cortex
Mooney, S. M. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh066 · Cited by 53 · see citing works
Földy, C., Aradi, I., Howard, A. L., & Soltész, I. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.03096.x · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Environment and Brain Plasticity: Towards an Endogenous Pharmacotherapy
Sale, A., Berardi, N., & Maffei, L. (2014) · Physiological Reviews · doi:10.1152/physrev.00036.2012 · Cited by 402 · see citing works
Olig1 and Olig2 triplication causes developmental brain defects in down syndrome.
Chakrabarti, L., Best, T. K., Cramer, N. P., Carney, R. S. E., Isaac, J. T. R., Galdzicki, Z., & Haydar, T. F. (2010) · Nature Neuroscience · doi:10.1038/nn.2600 · Cited by 258 · see citing works
The role of GABAergic signalling in neurodevelopmental disorders
Tang, X., Jaenisch, R., & Sur, M. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00443-x · Cited by 206 · see citing works
Deidda, G., Bozarth, I. F., & Cancedda, L. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00119 · Cited by 192 · see citing works
Xu, R., Brawner, A. T., Li, S., Liu, J.-J., Kim, H., Xue, H., Pang, Z. P., Kim, W.-Y., Hart, R. P., Liu, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.014 · Cited by 193 · see citing works
Kleschevnikov, A. M., Belichenko, P. V., Faizi, M., Jacobs, L. F., Htun, K. E., Shamloo, M., & Mobley, W. C. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1673-12.2012 · Cited by 174 · see citing works
Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities
Rueda, N., Flórez, J., & Martínez-Cué, C. (2012) · Neural Plasticity · doi:10.1155/2012/584071 · Cited by 171 · see citing works
DYRK1A and cognition: A lifelong relationship
Arbonés, M. L., Thomazeau, A., Nakano-Kobayashi, A., Hagiwara, M., & Delabar, J. M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.010 · Cited by 165 · see citing works
DYRK1A: A master regulatory protein controlling brain growth
Guedj, F., Pereira, P. L., Najas, S., Barallobre, M. J., Chabert, C., Souchet, B., Sebrié, C., Verney, C., Hérault, Y., Arbonés, M. L., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.007 · Cited by 155 · see citing works
Brain Plasticity and Disease: A Matter of Inhibition
Baroncelli, L., Braschi, C., Spolidoro, M., Begenisic, T., Maffei, L., & Sale, A. (2011) · Neural Plasticity · doi:10.1155/2011/286073 · Cited by 160 · see citing works
Martínez‐Cué, C., Martinez, P. M., Rueda, N., Vidal, R., García-Cerro, S., Vidal, V., Corrales, A., Montero, J. A., Pazos, Á., Flórez, J., et al. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1203-12.2013 · Cited by 154 · see citing works
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141 · see citing works
Kleschevnikov, A. M., Belichenko, P. V., Gall, J., George, L., Nosheny, R., Maloney, M. T., Salehi, A., & Mobley, W. C. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.009 · Cited by 124 · see citing works
Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage
Souchet, B., Guedj, F., Sahún, I., Duchon, A., Daubigney, F., Badel, A., Yanagawa, Y., Barallobre, M. J., Dierssen, M., Yu, E. Y., et al. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.04.016 · Cited by 112 · see citing works
García-Cerro, S., Martínez, P., Vidal, V., Corrales, A., Flórez, J., Vidal, R., Rueda, N., Arbonés, M. L., & Martínez-Cué, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106572 · Cited by 104 · see citing works
Kaphzan, H., Hernandez, P. J., Jung, J. I., Cowansage, K. K., Deinhardt, K., Chao, M. V., Abel, T. G., & Klann, E. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.021 · Cited by 92 · see citing works
Begenisic, T., Spolidoro, M., Braschi, C., Baroncelli, L., Milanese, M., Pietra, G., Fabbri, M. E., Bonanno, G., Cioni, G., Maffei, L., et al. (2011) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2011.00029 · Cited by 82 · see citing works
Is it possible to improve neurodevelopmental abnormalities in Down syndrome?
Bartesaghi, R., Guidi, S., & Ciani, E. (2011) · Reviews in the Neurosciences · doi:10.1515/rns.2011.037 · Cited by 74 · see citing works
Begenisic, T., Baroncelli, L., Sansevero, G., Milanese, M., Bonifacino, T., Bonanno, G., Cioni, G., Maffei, L., & Sale, A. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.010 · Cited by 66 · see citing works
Neural plasticity and memory: molecular mechanism
Amtul, Z., & Rahman, A. (2015) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0075 · Cited by 64 · see citing works
GABAergic over-inhibition, a promising hypothesis for cognitive deficits in Down syndrome
Martín, J. Z. D. S., Delabar, J. M., Bacci, A., & Potier, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.10.002 · Cited by 64 · see citing works
Souchet, B., Duchon, A., Gu, Y., Dairou, J., Chevalier, C., Daubigney, F., Nalesso, V., Créau, N., Yu, Y., Janel, N., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-40328-9 · Cited by 54 · see citing works
Treating enhanced GABAergic inhibition in Down syndrome: Use of GABA α5-selective inverse agonists
Martínez-Cué, C., Delatour, B., & Potier, M.-C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.12.008 · Cited by 58 · see citing works
Hanson, J. E., Weber, M., Meilandt, W. J., Wu, T. Z., Luu, T., Deng, L., Shamloo, M., Sheng, M., Scearce-Levie, K. A., & Zhou, Q. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.19 · Cited by 55 · see citing works
Pathophysiological power of improper tonic GABAA conductances in mature and immature models
Egawa, K., & Fukuda, A. (2013) · Frontiers in Neural Circuits · doi:10.3389/fncir.2013.00170 · Cited by 54 · see citing works
Goeldner, C., Kishnani, P. S., Skotko, B. G., Casero, J. L., Hipp, J. F., Derks, M., Hernandez, M.-C., Khwaja, O., Lennon-Chrimes, S., Noeldeke, J., et al. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-022-09418-0 · Cited by 48 · see citing works
Neurodevelopment in Down syndrome: Concordance in humans and models
Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47 · see citing works
“In concordance with human data, though in contrast to the previous work, another study found that there was an increase in the density of calretinin positive interneurons in the Ts65Dn neocortex and no overall increase in parvalbumin interneurons though the distribution of both interneurons types was significantly alt…”
ResultAltered Distribution of Hippocampal Interneurons in the Murine down Syndrome Model Ts65Dn.
Hernández-González, S., Ballestín, R., López-Hidalgo, R., Gilabert-Juan, J., Blasco-Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2015) · Neurochemical Research · doi:10.1007/s11064-014-1479-8 · Cited by 41 · see citing works
Self-citationThe roles of motor activity and environmental enrichment in intellectual disability
Giorgio, A. D. (2017) · Somatosensory & Motor Research · doi:10.1080/08990220.2016.1278204 · Cited by 40 · see citing works
Kurbatova, P., Wendling, F., Kamińska, A., Rosati, A., Nabbout, R., Guerrini, R., Dulac, O., Pons, G., Cornu, C., Nony, P., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.05.037 · Cited by 40 · see citing works
Stagni, F., & Bartesaghi, R. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.903729 · Cited by 31 · see citing works
Reducing Gabaergic Inhibition Restores Cognitive Functions in a Mouse Model of Down Syndrome
Potier, M.-C., Braudeau, J., Dauphinot, L., & Delatour, B. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660185 · Cited by 34 · see citing works
The in vivo Down syndrome genomic library in mouse
Hérault, Y., Duchon, A., Velot, É., Maréchal, D., & Brault, V. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00009-1 · Cited by 32 · see citing works
Paternò, R., Casalia, M. L., & Baraban, S. C. (2019) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2019.12.015 · Cited by 32 · see citing works
Sahafi, O. H., Sardari, M., Alijanpour, S., & Rezayof, A. (2023) · Brain Sciences · doi:10.3390/brainsci13050815 · Cited by 31 · see citing works
Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome
Rueda, N., Flórez, J., Dierssen, M., & Martínez‐Cué, C. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.001 · Cited by 29 · see citing works
New Perspectives for the Rescue of Cognitive Disability in Down Syndrome
Bartesaghi, R., Haydar, T. F., Delabar, J. M., Dierssen, M., Martínez‐Cué, C., & Bianchi, D. W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2775-15.2015 · Cited by 32 · see citing works
CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons
Elbert, A., Vogt, D. L., Watson, A., Levy, M. A., Jiang, Y. Y., Brûlé, E., Rowland, M. E., Rubenstein, J. L. R., & Bérubé, N. G. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.3496-17.2018 · Cited by 30 · see citing works
Créau, N. (2012) · Neural Plasticity · doi:10.1155/2012/171639 · Cited by 30 · see citing works
Kleschevnikov, A. M., Belichenko, P. V., Salehi, A., & Wu, C. (2012) · Progress in brain research · doi:10.1016/b978-0-444-54299-1.00010-8 · Cited by 29 · see citing works
Down syndrome and DYRK1A overexpression: relationships and future therapeutic directions
Murphy, A. J., Wilton, S. D., Aung-Htut, M. T., & McIntosh, C. S. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1391564 · Cited by 27 · see citing works
Dendrites of Neocortical Pyramidal Neurons: The Key to Understand Intellectual Disability
Granato, A., & Merighi, A. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01123-1 · Cited by 26 · see citing works
Brain circuit pathology in Down syndrome: from neurons to neural networks
Bartesaghi, R. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0067 · Cited by 25 · see citing works
Alterations of brain circuits in Down syndrome murine models
Gotti, S., Caricati, E., & Panzica, G. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.09.002 · Cited by 25 · see citing works
Hernández-González, S., Gilabert‐Juan, J., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2011) · Neuropeptides · doi:10.1016/j.npep.2011.10.002 · Cited by 25 · see citing works
Self-citationAsynchronous excitatory neuron development in an isogenic cortical spheroid model of Down syndrome
Li, Z., Klein, J. A., Rampam, S., Kurzion, R., Campbell, N. B., Patel, Y., Haydar, T. F., & Zeldich, E. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.932384 · Cited by 24 · see citing works
Genetic and Epigenetic Mechanisms in Down Syndrome Brain
Lu, J., & Shee, V. (2013) · InTech eBooks · doi:10.5772/52807 · Cited by 23 · see citing works
Illouz, T., Madar, R., Biragyn, A., & Okun, E. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2018.10.004 · Cited by 22 · see citing works
Abukhaled, Y., Hatab, K., Awadhalla, M., & Hamdan, H. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11890-0 · Cited by 21 · see citing works
GABAergic dysfunction in pediatric neuro-developmental disorders
Smith‐Hicks, C. L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00269 · Cited by 21 · see citing works
Guerreiro, S. R., & Maciel, P. (2023) · Cells · doi:10.3390/cells12040538 · Cited by 20 · see citing works
Mouton‐Liger, F., Sahún, I., Collin, T., Pereira, P. L., Masini, D., Thomas, S., Paly, E., Luilier, S., Même, S., Jouhault, Q., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.016 · Cited by 19 · see citing works
Brain (Hyper)Excitability Revealed by Optimal Electrical Stimulation of GABAergic Interneurons
Wendling, F., Gerber, U. R., Cosandier‐Rimélé, D., Nica, A., de Montigny, J., Raineteau, O., Kalitzin, S., Lopes, F. H. D. S., & Benquet, P. (2016) · Brain stimulation · doi:10.1016/j.brs.2016.07.001 · Cited by 17 · see citing works
Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis
López‐Hidalgo, R., Ballestín, R., Vega, J., Blasco‐Ibáñez, J. M., Crespo, C., Gilabert‐Juan, J., Nácher, J., & Varea, E. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00075 · Cited by 13 · see citing works
Self-citationMolecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Risgaard, R. D., Hanthanan Arachchilage, K., Knaack, S. A., Hosseini, M., Chen, R. J., Kumarage, P., Schmidt, D. K., Huang, X., Sheng, J., Wang, C. J., et al. (2026) · Science · doi:10.1126/science.aea1549 · Cited by 12 · see citing works
Neocortical neuronal production and maturation defects in the TcMAC21 mouse model of Down syndrome
Kurabayashi, N., Fujii, K., Otobe, Y., Hiroki, S., Hiratsuka, M., Yoshitane, H., Kazuki, Y., & Takao, K. (2023) · iScience · doi:10.1016/j.isci.2023.108379 · Cited by 13 · see citing works
Shaking up the silence: consequences of HMGN1 antagonizing PRC2 in the Down syndrome brain
Farley, S. J., Grishok, A., & Zeldich, E. (2022) · Epigenetics & Chromatin · doi:10.1186/s13072-022-00471-6 · Cited by 13 · see citing works
Victorino, D. B., Pinheiro, D. J. L. L., Scott-McKean, J. J., Barker, S., Stasko, M. R., Faber, J., Scorza, C. A., & Costa, A. C. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-89011-y · Cited by 11 · see citing works
Piriform cortex alterations in the Ts65Dn model for down syndrome
Carbonell, J., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147031 · Cited by 9 · see citing works
Self-citationGABAergic Circuit Development and Its Implication for CNS Disorders
Cristo, G. D., Pizzorusso, T., Cancedda, L., & Sernagor, E. (2011) · Neural Plasticity · doi:10.1155/2011/623705 · Cited by 9 · see citing works
Dysfunctions of cellular context-sensitivity in neurodevelopmental learning disabilities
Granato, A., Phillips, W. A., Schulz, J. M., Mototaka Suzuki, A., & Larkum, M. E. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105688 · Cited by 8 · see citing works
Early increased density of cyclooxygenase-2 (COX-2) immunoreactive neurons in Down syndrome
Mulet, M., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2017) · Folia Neuropathologica · doi:10.5114/fn.2017.68582 · Cited by 7 · see citing works
Self-citationFragile X cortex is characterized by decreased parvalbumin-expressing interneurons
Juárez, P., Salcedo‐Arellano, M. J., Dufour, B. D., & Martínez‐Cerdeño, V. (2024) · Cerebral Cortex · doi:10.1093/cercor/bhae103 · Cited by 5 · see citing works
Cholinergic Senescence in the Ts65Dn Mouse Model for Down Syndrome
Kirstein, M., Cambrils, A., Segarra, A., Melero, A., & Varea, E. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03659-0 · Cited by 6 · see citing works
Self-citationWilliam, C. M., Saqran, L., Stern, M. A., Chiang, C. L., Herrick, S. P., Rangwala, A., Albers, M. W., Frosch, M. P., & Hyman, B. T. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1045-17.2017 · Cited by 6 · see citing works
López‐Hidalgo, R., Ballestín, R., Lorenzo, L., Sánchez-Martí, S., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105679 · Cited by 4 · see citing works
Self-citationTrisomie 21, Demenz vom Alzheimer-Typ und Epilepsie
Martin, P. (2011) · Clinical Epileptology · doi:10.1007/s10309-011-0212-8 · Cited by 5 · see citing works
Combinatorial Gene Effects on the Neural Progenitor Pool in Down Syndrome
Lu, J., & Sheen, V. (2011) · InTech eBooks · doi:10.5772/20888 · Cited by 1 · see citing works
Alterations in reelin and reelin receptors in Down syndrome
Bellés, M., Carbonell, J., Blasco‐Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001153 · Cited by 4 · see citing works
Self-citationGuzmán-Muñoz, E., Méndez-Rebolledo, G., Villouta-Gutiérrez, O., Concha‐Cisternas, Y., & Valdés-Badilla, P. A. (2019) · Neurología Argentina · doi:10.1016/j.neuarg.2019.02.004 · Cited by 3 · see citing works
All-Optical Wavelength-Selective Switch by Intensity Control in Cascaded Interferometers
Kishikawa, H., Goto, N., & Kimiy, K. (2010) · InTech eBooks · doi:10.5772/39555 · Cited by 3 · see citing works
Hannan, S., Lana-Elola, E., Watson-Scales, S., Fisher, E. M. C., Tybulewicz, V. L. J., & Smart, T. G. (2025) · bioRxiv · doi:10.1101/2025.07.21.665861 · Cited by 3 · see citing works
Adults with down syndrome exhibit altered somatosensory cortical inhibition
Meejang, J., Busboom, M. T., Baker, S. E., Arif, Y., Kastner, O., Wilson, T. W., & Kurz, M. J. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103797 · Cited by 2 · see citing works
Atak, Z., Srivastava, A., Gandhi, S., Park, E., Williams, J., Torii, M., & Haydar, T. F. (2025) · Journal of Neuroscience · doi:10.1523/jneurosci.0040-25.2025 · Cited by 2 · see citing works
Cognitive deficits in Down syndrome: narrowing ‘Down’ to Olig1 and Olig2
Wong, B. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01556_3.x · Cited by 2 · see citing works
Increased dendritic inhibition of dentate gyrus granule cells in a mouse model of Down syndrome
Gutmann, N., Häussler, U., Mersi, A., Follo, M., Bischofberger, J., & Schulz, J. M. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1714586 · Cited by 1 · see citing works
Bowman, A. B., Ess, K. C., Kumar, K. K., & Summar, K. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00130-8 · Cited by 1 · see citing works
Savardi, A., Ziogas, I., Bolla, M., & Cancedda, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815318-5.00021-2 · Cited by 1 · see citing works
Modeling Down Syndrome Neurodevelopment with Dosage Compensation
Czerminski, J. T. (2019) · eScholarship@UMassChan · doi:10.13028/j7xf-1q21 · Cited by 1 · see citing works
The role of filopodia in the formation of spine synapses
Arstikaitis, P. (2011) · cIRcle (University of British Columbia) · doi:10.14288/1.0071638 · Cited by 1 · see citing works
Sa'diyah, C. (2014) · SKRIPSI Jurusan Kependidikan Sekolah Dasar & Prasekolah - Fakultas Ilmu Pendidikan UM
Imbalance in glutamatergic and GABAergic transmission in Down syndrome and therapeutic targets
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00007-7
Persons with down syndrome exhibit altered sensorimotor cortical oscillations
Kurz, M. J., Meejang, J., Busboom, M. T., Rempe, M. P., & Wilson, T. W. (2026) · The Journal of Precision Medicine Health and Disease · doi:10.1016/j.premed.2026.100066
Pharmacological Rescue of Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome
Stagni, F. (2014) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6201
- Authors
- Pérez-Cremades, D., Hernández, S., Blasco-Ibáñez, J. M., Crespo, C., Nacher, J., & Varea, E.
- Affiliations
- Universitat de València (ES)
- Corresponding author
- Varea, E.
- ORCID
- Venue
- Journal of Neural Transmission
- Published
- 2010-02-16
- Volume
- 117
- Issue
- 4
- Pages
- 445-455
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W1968751712
- Cited by
- 85
- References
- 45
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 3 · 2015: 2 · 2014: 9 · 2013: 8 · 2012: 7
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc
- www.springer.com/tdm (tdm)
- Locations
- Journal of Neural Transmission (publishedVersion)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by-nc)
- Repository of Digital Objects for Teaching Research and Culture (University of Valencia) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Down syndrome, Ts65Dn mouse model, somatosensory cortex, inhibitory interneurons, GAD67, synaptophysin, calretinin, dendritic branching, neuronal inhibition, epilepsy, intellectual disability
- MeSH terms
- Aging, Animals, Calcium-Binding Proteins, Cell Count, Disease Models, Animal, Down Syndrome, Glutamate Decarboxylase, Immunohistochemistry, Interneurons, Male, Mice, Transgenic, Neural Inhibition, Neural Pathways, Somatosensory Cortex, Synapses, Synaptophysin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review